Please login to the form below

Not currently logged in
Email:
Password:

La Jolla Pharmaceutical

This page shows the latest La Jolla Pharmaceutical news and features for those working in and with pharma, biotech and healthcare.

Tecentriq’s triple negative breast cancer use among key CHMP nods

Tecentriq’s triple negative breast cancer use among key CHMP nods

Extensions for AZ drugs, new approval for La Jolla. Roche’s Tecentriq has gained a recommendation for approval in triple-negative breast cancer from Europe’s CHMP, setting it on track ... Among other positive news was La Jolla Pharmaceutical’s

Latest news

  • La Jolla plans filing on back of blood pressure trial data La Jolla plans filing on back of blood pressure trial data

    US biotech La Jolla Pharmaceutical added 76% to the value of its shares yesterday after it reported data from a phase III trial showing its drug for low blood pressure. ... La Jolla estimates that there are around half a million distributive shock cases

  • News in brief, May 17, 2007

    Roche inaugurates biotech production centre in Switzerland. Swiss pharmaceutical company Roche has opened a new biotechnology production centre in Basel. ... New CFO for La Jolla Pharmaceuticals. US pharmaceutical company, La Jolla, has hired Niv E

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics